Stem cell therapy: Boon or bane? A comprehensive study on the inadequacy of the DOH administrative order 2013-012 and FDA circular 2013-017, regulatory policies on the administration of stem cell products in hospitals, clinics, and laboratories

This thesis paper entitled, Stem Cell Therapy: boon or bane? intends to provide a comprehensive study on the inadequacies of the DOH Administrative Order 2013-0012 and FDA Circular 2013-017, which are the relevant administrative orders governing the use of stem cell products in hospitals, clinics, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Andres, Conrado I., Lacap, Jeanette N.
Format: text
Language:English
Published: Animo Repository 2013
Subjects:
Law
Online Access:https://animorepository.dlsu.edu.ph/etd_bachelors/5453
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: De La Salle University
Language: English
id oai:animorepository.dlsu.edu.ph:etd_bachelors-5988
record_format eprints
spelling oai:animorepository.dlsu.edu.ph:etd_bachelors-59882021-11-06T01:24:28Z Stem cell therapy: Boon or bane? A comprehensive study on the inadequacy of the DOH administrative order 2013-012 and FDA circular 2013-017, regulatory policies on the administration of stem cell products in hospitals, clinics, and laboratories Andres, Conrado I. Lacap, Jeanette N. This thesis paper entitled, Stem Cell Therapy: boon or bane? intends to provide a comprehensive study on the inadequacies of the DOH Administrative Order 2013-0012 and FDA Circular 2013-017, which are the relevant administrative orders governing the use of stem cell products in hospitals, clinics, and laboratories.The aforementioned administrative orders will be discussed in light of the provisions provided for under the FDA Act of 2009 and the Consumer Act of the Philippines. The relevant provisions of the said statutes will be exhausted in order to establish the objectives of the paper, which are: (1) to establish the inadequacy of the DOH Administrative Order 2013-12 and FDA Circular 2013-17 and (2) to propose a bill that shall cover the inadequacies of the DOH Administrative Order and FDA Circular. 2013-01-01T08:00:00Z text https://animorepository.dlsu.edu.ph/etd_bachelors/5453 Bachelor's Theses English Animo Repository Stem cells—Transplantation--Law and legislation--Philippines Law Medical Jurisprudence
institution De La Salle University
building De La Salle University Library
continent Asia
country Philippines
Philippines
content_provider De La Salle University Library
collection DLSU Institutional Repository
language English
topic Stem cells—Transplantation--Law and legislation--Philippines
Law
Medical Jurisprudence
spellingShingle Stem cells—Transplantation--Law and legislation--Philippines
Law
Medical Jurisprudence
Andres, Conrado I.
Lacap, Jeanette N.
Stem cell therapy: Boon or bane? A comprehensive study on the inadequacy of the DOH administrative order 2013-012 and FDA circular 2013-017, regulatory policies on the administration of stem cell products in hospitals, clinics, and laboratories
description This thesis paper entitled, Stem Cell Therapy: boon or bane? intends to provide a comprehensive study on the inadequacies of the DOH Administrative Order 2013-0012 and FDA Circular 2013-017, which are the relevant administrative orders governing the use of stem cell products in hospitals, clinics, and laboratories.The aforementioned administrative orders will be discussed in light of the provisions provided for under the FDA Act of 2009 and the Consumer Act of the Philippines. The relevant provisions of the said statutes will be exhausted in order to establish the objectives of the paper, which are: (1) to establish the inadequacy of the DOH Administrative Order 2013-12 and FDA Circular 2013-17 and (2) to propose a bill that shall cover the inadequacies of the DOH Administrative Order and FDA Circular.
format text
author Andres, Conrado I.
Lacap, Jeanette N.
author_facet Andres, Conrado I.
Lacap, Jeanette N.
author_sort Andres, Conrado I.
title Stem cell therapy: Boon or bane? A comprehensive study on the inadequacy of the DOH administrative order 2013-012 and FDA circular 2013-017, regulatory policies on the administration of stem cell products in hospitals, clinics, and laboratories
title_short Stem cell therapy: Boon or bane? A comprehensive study on the inadequacy of the DOH administrative order 2013-012 and FDA circular 2013-017, regulatory policies on the administration of stem cell products in hospitals, clinics, and laboratories
title_full Stem cell therapy: Boon or bane? A comprehensive study on the inadequacy of the DOH administrative order 2013-012 and FDA circular 2013-017, regulatory policies on the administration of stem cell products in hospitals, clinics, and laboratories
title_fullStr Stem cell therapy: Boon or bane? A comprehensive study on the inadequacy of the DOH administrative order 2013-012 and FDA circular 2013-017, regulatory policies on the administration of stem cell products in hospitals, clinics, and laboratories
title_full_unstemmed Stem cell therapy: Boon or bane? A comprehensive study on the inadequacy of the DOH administrative order 2013-012 and FDA circular 2013-017, regulatory policies on the administration of stem cell products in hospitals, clinics, and laboratories
title_sort stem cell therapy: boon or bane? a comprehensive study on the inadequacy of the doh administrative order 2013-012 and fda circular 2013-017, regulatory policies on the administration of stem cell products in hospitals, clinics, and laboratories
publisher Animo Repository
publishDate 2013
url https://animorepository.dlsu.edu.ph/etd_bachelors/5453
_version_ 1718382573887946752